Company intelligence / Profile preview

Osstem Cardiotec

Goyang-si, Gyeonggi-do, South Koreapmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Commercial

Overview

Osstem Cardiotec is a South Korean company specializing in cardiovascular medical technology and devices. It was originally known as Cardiotech Co., Ltd. before being acquired by Osstem Implant and renamed in 2016. The company operates as part of the broader Osstem group, which is recognized for its leadership in dental implants and healthcare solutions.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Centum

Commercial

Indications: Coronary artery disease

Beyond the preview

Go deeper on Osstem Cardiotec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osstem Cardiotec.

Explore the full profile